Menu
Search
|

Menu

Close
X

NuVasive Inc NUVA.OQ (NASDAQ Stock Exchange Global Select Market)

53.89 USD
-0.33 (-0.61%)
As of Jul 13
chart
Previous Close 54.22
Open 54.44
Volume 227,699
3m Avg Volume 214,075
Today’s High 55.13
Today’s Low 53.73
52 Week High 81.48
52 Week Low 44.62
Shares Outstanding (mil) 51.26
Market Capitalization (mil) 2,762.40
Forward P/E 131.63
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.47 Mean rating from 17 analysts

KEY STATS

Revenue (mm, USD)
FY18
261
FY17
1,029
FY16
962
FY15
811
EPS (USD)
FY18
-0.530
FY17
1.154
FY16
0.685
FY15
1.269
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
131.63
33.20
Price to Sales (TTM)
vs sector
2.66
8.07
Price to Book (MRQ)
vs sector
3.62
4.28
Price to Cash Flow (TTM)
vs sector
18.92
22.38
Total Debt to Equity (MRQ)
vs sector
84.30
17.39
LT Debt to Equity (MRQ)
vs sector
77.09
13.21
Return on Investment (TTM)
vs sector
1.61
13.23
Return on Equity (TTM)
vs sector
3.24
15.28

EXECUTIVE LEADERSHIP

Gregory Lucier
Chairman of the Board, Chief Executive Officer, Since 2015
Salary: $833,649.00
Bonus: --
Rajesh Asarpota
Principal Financial Officer, Executive Vice President, Principal Accounting Officer, Since 2018
Salary: $134,462.00
Bonus: --
Joan Stafslien
Executive Vice President, General Counsel, Corporate Secretary, Since 2016
Salary: --
Bonus: --
Carol Cox
Executive Vice President - External Affairs and Corporate Marketing, Since 2015
Salary: --
Bonus: --
Harry Kiil
Executive Vice President, Global Commercial, Since 2017
Salary: $257,808.00
Bonus: $800,000.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

7475 Lusk Blvd
SAN DIEGO   CA   92121-5707

Phone: +1858.9091800

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.

SPONSORED STORIES